实用肿瘤学杂志
實用腫瘤學雜誌
실용종류학잡지
JOURNAL OF PRACTICAL ONCOLOGY
2014年
3期
193-197
,共5页
韩嘉晟%吴华星%孟德新%徐爱军%孟蕊
韓嘉晟%吳華星%孟德新%徐愛軍%孟蕊
한가성%오화성%맹덕신%서애군%맹예
肺癌%细胞因子%免疫功能
肺癌%細胞因子%免疫功能
폐암%세포인자%면역공능
Lung cancer%Cytokine%Immune function
目的:研究围术期肺癌患者CD4+/CD8+T细胞与TGF-β、IL-4、IL-6的含量变化及临床意义。方法分别采用流式细胞术(Flow cytometry,FCM)及酶联免疫吸附法(ELISA)检测20例肺癌患者手术前后和10例正常对照者CD4+T、CD8+T细胞比例及细胞因子TGF-β、IL-4和IL-6的含量。结果20例肺癌患者术前CD4+T、CD8+T细胞比例分别为(46.26±4.26)%、(43.15±5.18)%,术后5天分别为(44.30±4.25)%、(39.80±2.53)%;肺癌患者术前血清中TGF-β、IL-4、IL-6的含量分别为(240.51±46.37)pg/mL、(19.85±2.52) pg/mL、(129.28±33.06) pg/mL,术后5天分别为(210.79±36.94) pg/mL、(17.37±2.57) pg/mL、(107.28±27.83) pg/mL。两组之间差异均有统计学意义( P<0.05)。结论围术期肺癌患者的免疫状态呈先抑制后恢复,监测围术期CD4+/CD8+T细胞与TGF-β、IL-4、IL-6的含量变化对肿瘤患者病情监测及预后判断具有重要意义。
目的:研究圍術期肺癌患者CD4+/CD8+T細胞與TGF-β、IL-4、IL-6的含量變化及臨床意義。方法分彆採用流式細胞術(Flow cytometry,FCM)及酶聯免疫吸附法(ELISA)檢測20例肺癌患者手術前後和10例正常對照者CD4+T、CD8+T細胞比例及細胞因子TGF-β、IL-4和IL-6的含量。結果20例肺癌患者術前CD4+T、CD8+T細胞比例分彆為(46.26±4.26)%、(43.15±5.18)%,術後5天分彆為(44.30±4.25)%、(39.80±2.53)%;肺癌患者術前血清中TGF-β、IL-4、IL-6的含量分彆為(240.51±46.37)pg/mL、(19.85±2.52) pg/mL、(129.28±33.06) pg/mL,術後5天分彆為(210.79±36.94) pg/mL、(17.37±2.57) pg/mL、(107.28±27.83) pg/mL。兩組之間差異均有統計學意義( P<0.05)。結論圍術期肺癌患者的免疫狀態呈先抑製後恢複,鑑測圍術期CD4+/CD8+T細胞與TGF-β、IL-4、IL-6的含量變化對腫瘤患者病情鑑測及預後判斷具有重要意義。
목적:연구위술기폐암환자CD4+/CD8+T세포여TGF-β、IL-4、IL-6적함량변화급림상의의。방법분별채용류식세포술(Flow cytometry,FCM)급매련면역흡부법(ELISA)검측20례폐암환자수술전후화10례정상대조자CD4+T、CD8+T세포비례급세포인자TGF-β、IL-4화IL-6적함량。결과20례폐암환자술전CD4+T、CD8+T세포비례분별위(46.26±4.26)%、(43.15±5.18)%,술후5천분별위(44.30±4.25)%、(39.80±2.53)%;폐암환자술전혈청중TGF-β、IL-4、IL-6적함량분별위(240.51±46.37)pg/mL、(19.85±2.52) pg/mL、(129.28±33.06) pg/mL,술후5천분별위(210.79±36.94) pg/mL、(17.37±2.57) pg/mL、(107.28±27.83) pg/mL。량조지간차이균유통계학의의( P<0.05)。결론위술기폐암환자적면역상태정선억제후회복,감측위술기CD4+/CD8+T세포여TGF-β、IL-4、IL-6적함량변화대종류환자병정감측급예후판단구유중요의의。
Objective To study the changes of CD4 +/CD8 +T cells ratio and TGF -β,IL-4,IL-6 levels in lung cancer patients during the perioperative period and to analyze the clinical significance .Methods Flow cytometer and Elisa were used to analyze the CD 4 +/CD8 +T cells ratio and TGF-β,IL-4,IL-6 levels in peripheral blood sapmles from 20 patients with lung cancer during the perioperative period and 10 healthy con-trolsR. esults Before operation ,the ratios of CD4 +T and CD8 +T cells from 20 patients with lung cancer were (46.26 ±4.26)%and(43.15 ±5.18)%, respectively.On the fifth day after operation ,the ratios of CD4 +T and CD8 +T cells were(44.30 ±4.25)%and(39.80 ±2.53)%.TGF-β,IL-4 and IL-6 levels in 20lung cancer patients were(240.51 ±46.37)pg/mL,(19.85 ±2.52)pg/mL,and(129.28 ±33.06)pg/mL,respectively.On the fifth day after operation,TGF-β,IL-4 and IL-6 levels were(210.79 ±36.94)pg/mL,(17.37 ±2.57) pg/mL,and(107.28 ±27.83) pg/mL.The differences of above parameters between the preoperative period and the fifth day after operation were statistically significant ( P<0.05) . Conclusion The immune suppression oc-curs before its recovery during perioperative period ,the changes of CD4 +/CD8 +T cells ratio and TGF-β,IL-4 and IL-6 levels have significance on monitoring the progress and prognosis of patients with tumor .